Cellular immunity in acne vulgaris during transfer factor treatment. 1985

R Ashorn, and A Uotila, and K Kuokkanen, and L Räsänen, and E Karhumäki, and K Krohn

The effect of treatment with human dialyzable transfer factor was investigated on acne vulgaris patients in a double-blind study. About 1/3 of the patients improved clinically during the study period but there was no correlation between clinical improvement and transfer factor treatment. Prior to treatment parameters of cell-mediated immunity were significantly altered in the patients. These alterations normalized during the study in all patients irrespective of transfer factor treatment, possibly due to the immunostimulatory effect of repeated skin testing. The present results support previous findings that acne patients have slightly altered cell-mediated immunity, but the results further suggest that abnormalities are not significant in the pathogenesis of acne vulgaris.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000152 Acne Vulgaris A chronic disorder of the pilosebaceous apparatus associated with an increase in sebum secretion. It is characterized by open comedones (blackheads), closed comedones (whiteheads), and pustular nodules. The cause is unknown, but heredity and age are predisposing factors. Acne
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012882 Skin Tests Epicutaneous or intradermal application of a sensitizer for demonstration of either delayed or immediate hypersensitivity. Used in diagnosis of hypersensitivity or as a test for cellular immunity. Skin Test,Test, Skin,Tests, Skin
D014165 Transfer Factor Factor derived from leukocyte lysates of immune donors which can transfer both local and systemic cellular immunity to nonimmune recipients. Dialyzable Leukocyte Extract,Extract, Dialyzable Leukocyte,Factor, Transfer,Leukocyte Extract, Dialyzable

Related Publications

R Ashorn, and A Uotila, and K Kuokkanen, and L Räsänen, and E Karhumäki, and K Krohn
January 1974, Harvey lectures,
R Ashorn, and A Uotila, and K Kuokkanen, and L Räsänen, and E Karhumäki, and K Krohn
February 1979, The Journal of allergy and clinical immunology,
R Ashorn, and A Uotila, and K Kuokkanen, and L Räsänen, and E Karhumäki, and K Krohn
February 1976, Acta pathologica et microbiologica Scandinavica. Section C, Immunology,
R Ashorn, and A Uotila, and K Kuokkanen, and L Räsänen, and E Karhumäki, and K Krohn
July 1978, The British journal of dermatology,
R Ashorn, and A Uotila, and K Kuokkanen, and L Räsänen, and E Karhumäki, and K Krohn
November 1976, Journal of theoretical biology,
R Ashorn, and A Uotila, and K Kuokkanen, and L Räsänen, and E Karhumäki, and K Krohn
June 1985, Ceskoslovenska pediatrie,
R Ashorn, and A Uotila, and K Kuokkanen, and L Räsänen, and E Karhumäki, and K Krohn
June 2013, Drugs,
R Ashorn, and A Uotila, and K Kuokkanen, and L Räsänen, and E Karhumäki, and K Krohn
February 1963, Clinical medicine (Northfield, Ill.),
R Ashorn, and A Uotila, and K Kuokkanen, and L Räsänen, and E Karhumäki, and K Krohn
July 1951, Journal of the American Medical Association,
R Ashorn, and A Uotila, and K Kuokkanen, and L Räsänen, and E Karhumäki, and K Krohn
July 1954, Medical times,
Copied contents to your clipboard!